Molecular Description of Familial Defective APOB-100 in Malaysia

被引:6
|
作者
Al-Khateeb, Alyaa R. [1 ,2 ]
Mohd, Mohd Sapawi [3 ]
Yusof, Zukarnai [4 ]
Zilfalil, Bin Alwi [2 ]
机构
[1] Univ Teknol MARA UiTM, Fac Med, Jalan Hosp, Sungai Buloh 47000, Selangor, Malaysia
[2] Univ Sains Malaysia, Sch Med Sci, Ctr Human Genome, Kubang Kerian 16150, Kelantan, Malaysia
[3] Hosp Sultanah Nur Zahirah, Kuala Terengganu, Terengganu, Malaysia
[4] Univ Sains Malaysia, Sch Med Sci, Dept Med, Kubang Kerian 16150, Kelantan, Malaysia
关键词
APOB-100; gene; Familial defective APOB-100; Mutation; DHPLC; LIPOPROTEIN RECEPTOR GENE; APOLIPOPROTEIN B-100; B GENE; APO-B; MUTATION; HYPERCHOLESTEROLEMIA; IDENTIFICATION;
D O I
10.1007/s10528-013-9609-6
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Familial ligand-defective apolipoprotein B-100 is characterized by elevated plasma low-density lipoprotein levels and premature heart disease. This study aims to determine apolipoprotein B gene mutations among Malaysians with clinical diagnoses of familial hypercholesterolemia and to compare the phenotype of patients with apolipoprotein B gene mutations to those with a low-density lipoprotein receptor gene mutation. A group of 164 patients with a clinical diagnosis of familial hypercholesterolemia was analyzed. Amplicons in exon 26 and exon 29 of the apolipoprotein B gene were screened for genetic variants using denaturing gradient high-performance liquid chromatography; 10 variants were identified. Five novel mutations were detected (p.Gln2485Arg, p.Thr3526Ala, p.Glu3666Lys, p.Tyr4343CysfsX221, and p.Arg4297His). Those with familial defective apolipoprotein had a less severe phenotype than those with familial hypercholesterolemia. An apolipoprotein gene defect is present among Malaysian familial hypercholesterolemics. Those with both mutations show a more severe phenotype than those with one gene defect.
引用
收藏
页码:811 / 823
页数:13
相关论文
共 50 条
  • [21] Distinct Metabolism of Apo(a) and ApoB-100 Within Plasma Lp(a)
    Diffenderfer, Margaret R.
    Lamon-Fava, Stefania
    Marcovina, Santica M.
    Barrett, P. H.
    Berglund, Lars
    Schaefer, Ernst J.
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2014, 34
  • [22] Plasma lipoprotein(a) levels in familial defective ApoB
    Evans, David
    Beil, Frank U.
    Mann, W. Alexander
    CLINICAL LIPIDOLOGY, 2014, 9 (03) : 305 - 310
  • [23] 家族性apoB-100缺陷的分子基础
    况少青
    国际遗传学杂志, 1994, (04) : 192 - 195
  • [24] ApoB-100 metabolism in NIDDM patients using stable isotopes
    Maugeais, C
    Ouguerram, K
    Mahot, P
    Krempf, M
    Magot, T
    ATHEROSCLEROSIS, 1997, 134 (1-2) : 312 - 312
  • [25] Effects of ApoE genotype on ApoB-48 and ApoB-100 kinetics with stable isotopes in humans
    Welty, FK
    Lichtenstein, AH
    Barrett, PHR
    Jenner, JL
    Dolnikowski, GG
    Schaefer, EJ
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2000, 20 (07) : 1807 - 1810
  • [26] Effect of Ezetimibe on the in vivo kinetics of ApoB-48 and ApoB-100 in men with primary hypercholesterolemia
    Tremblay, AJ
    Lamarche, B
    Cohn, JS
    Hogue, JC
    Couture, P
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2006, 26 (05) : 1101 - 1106
  • [27] Increased production of VLDL apoB-100 in subjects with familial hypercholesterolemia carrying the same null LDL receptor gene mutation
    Tremblay, AJ
    Lamarche, B
    Ruel, IL
    Hogue, JC
    Bergeron, J
    Gagné, C
    Couture, P
    JOURNAL OF LIPID RESEARCH, 2004, 45 (05) : 866 - 872
  • [28] Hepatic secretion of apoB-100 is impaired in hypobetalipoproteinemic mice with an apoB-38.9-specifying allele
    Chen, ZJ
    Fitzgerald, RL
    Li, G
    Davidson, NO
    Schonfeld, G
    JOURNAL OF LIPID RESEARCH, 2004, 45 (01) : 155 - 163
  • [29] Inhibition of cholesterogenesis decreases hepatic secretion of apoB-100 in normolipidemic subjects
    Watts, GF
    Naoumova, RP
    Kelly, JM
    Riches, FM
    Croft, KD
    Thompson, GR
    AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 1997, 273 (03): : E462 - E470
  • [30] The mutation APOB-100 R3500Q in Eastern Europe
    Horvath, A
    Ganev, V
    ATHEROSCLEROSIS, 2001, 156 (01) : 241 - 242